Age-related macular degeneration, Eye disease , Geographic atrophy

Macular degeneration, Inflammatory disease, Autoimmune disease

IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.

Drug & Indication	Stage & Event	Catalyst Date
IZERVAY™ (avacincaptad pegol intravitreal solution) Details Age-related macular degeneration, Eye disease , Geographic atrophy	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Zimura (avacincaptad pegol) Details Macular degeneration, Inflammatory disease, Autoimmune disease	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.

Drug Pipeline

Powered by